Extended Duration Vascular Endothelial Growth Factor Inhibition in the Eye: Failures, Successes, and Future Possibilities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extended Duration Vascular Endothelial Growth Factor Inhibition in the Eye: Failures, Successes, and Future Possibilities

Published:2018-01-27 Issue:1 Volume:10 Page:21
ISSN:1999-4923
Container-title:Pharmaceutics
language:en
Short-container-title:Pharmaceutics

Author:

Stewart Michael

Publisher

MDPI AG

Subject

Pharmaceutical Science

Link

http://www.mdpi.com/1999-4923/10/1/21/pdf

Reference55 articles.

1. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

2. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

3. Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

4. DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

5. American Academy of Ophthalmologyhttps://www.aao.org/eyenet/article/treat-extend-strategy-is-there-consensus

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1;PLOS ONE;2024-07-11

2. Imaging of Adult Malignant Soft Tissue Tumors of the Spinal Canal: A Guide for Spine Surgeons;World Neurosurgery;2024-07

3. Hydrogel nanoparticles as new drug delivery system for CNS disorders;ChemistrySelect;2024-02-21

4. Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose;Pharmaceutics;2023-05-06

5. Therapeutic utility of engineered myeloid cells in the tumor microenvironment;Cancer Gene Therapy;2023-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3